SAINTE-FOY, QUEBEC -- (MARKET WIRE) -- May 01, 2007 -- Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer and supplier of taxane active pharmaceutical ingredients (APIs) and developer of targeted oncology drugs, announced today that it is expanding its paclitaxel API listings to ten additional countries; bringing to twenty three the number of European countries in which Bioxel will sell its paclitaxel product in the near term.
